Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Brian N Cherry

Director at Atara Biotherapeutics, Inc. (ATRA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$12K
Total bought / sold$1000K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Sep 4SEC ATRAAtara Biotherapeutics, Inc. Buy 104,166166,486 held (+167%) $9.60 $1000K -1.2%
  • Buy

    Director Brian N Cherry bought $1000K of ATRA at $9.60 — first open-market purchase in our records; raises the stake by 167%.